1. Multiplexed imaging for diagnosis and therapy
   Kathrin Heinzmann et al, 2017, Nature Biomedical Engineering CrossRef
2. Bimodal Imaging Probes for Combined PET and OI: Recent Developments and Future Directions for Hybrid Agent Development
   Uwe Seibold et al, 2014, BioMed Research International CrossRef
3. PET/Fluorescence Imaging: An Overview of the Chemical Strategies to Build Dual Imaging Tools
   Julen Ariztia et al, 2022, Bioconjugate Chemistry CrossRef
4. Fluorescent Tracers, Hybrid Tracers
   Dawid Murawa et al, 2016, Radioguided Surgery CrossRef
5. In Vivo Diffuse Optical Tomography and Fluorescence Molecular Tomography
   Mingze Li et al, 2010, Journal of Healthcare Engineering CrossRef
6. Multimodal radio- (PET/SPECT) and fluorescence imaging agents based on metallo-radioisotopes: current applications and prospects for development of new agents
   Flora L. Thorp-Greenwood et al, 2011, Dalton Transactions CrossRef
7. Production of highly purified no-carrier-added 177Lu for radioimmunotherapy
   Satoshi Watanabe et al, 2015, Journal of Radioanalytical and Nuclear Chemistry CrossRef
8. Dual PET and Near-Infrared Fluorescence Imaging Probes as Tools for Imaging in Oncology
   Fei-Fei An et al, 2016, American Journal of Roentgenology CrossRef
9. Targeted multimodal imaging modalities
   Seung Yong Lee et al, 2014, Advanced Drug Delivery Reviews CrossRef
10. 16
    R. W. Sabnis, 2015, Handbook of Fluorescent Dyes and Probes CrossRef
11. Near‐Infrared‐Emitting BODIPY‐trisDOTA111In as a Monomolecular Multifunctional Imaging Probe: From Synthesis to In Vivo Investigations
    Nicolas Maindron et al, 2016, Chemistry – A European Journal CrossRef
12. Recent trends in antibody-based oncologic imaging
    Sukhwinder Kaur et al, 2012, Cancer Letters CrossRef
13. Dual-Labelling Strategies for Nuclear and Fluorescence Molecular Imaging: Current Status and Future Perspectives
    Manja Kubeil et al, 2022, Pharmaceuticals CrossRef
14. Lymphoma: current status of clinical and preclinical imaging with radiolabeled antibodies
    Christopher G. England et al, 2017, European Journal of Nuclear Medicine and Molecular Imaging CrossRef
15. Chemoenzymatic Strategy for the Synthesis of Site-Specifically Labeled Immunoconjugates for Multimodal PET and Optical Imaging
    Brian M. Zeglis et al, 2014, Bioconjugate Chemistry CrossRef
16. Molecularly targeted nanoparticles: an emerging tool for evaluation of expression of the receptor for advanced glycation end products in a murine model of peripheral artery disease
    Marcin Woźniak et al, 2021, Cellular & Molecular Biology Letters CrossRef
17. Targeted Radionuclide and Fluorescence Dual-modality Imaging of Cancer: Preclinical Advances and Clinical Translation
    S. Lütje et al, 2014, Molecular Imaging and Biology CrossRef
18. Dual-Labeling Strategies for Nuclear and Fluorescence Molecular Imaging: A Review and Analysis
    Ali Azhdarinia et al, 2012, Molecular Imaging and Biology CrossRef
19. Positron emission tomography imaging and biodistribution of vascular endothelial growth factor with 64Cu‐labeled bevacizumab in colorectal cancer xenografts
    Bishnuhari Paudyal et al, 2011, Cancer Science CrossRef
20. Non‐Nanoparticle‐Based Dual‐Modality Imaging Agents
    Reinier Hernandez et al, 2014, The Chemistry of Molecular Imaging CrossRef
21. Drug Discovery by Molecular Imaging and Monitoring Therapy Response in Lymphoma
    Senthilkumar Kalimuthu et al, 2017, International Journal of Molecular Sciences CrossRef
22. Fluorine‐18 Radiolabelling and Photophysical Characteristics of Multimodal PET–Fluorescence Molecular Probes
    Mitchell A. Klenner et al, 2021, Chemistry – A European Journal CrossRef
23. Site-Specific Fluorescent Labeling of Antibodies and Diabodies Using SpyTag/SpyCatcher System for In Vivo Optical Imaging
    Md. Kausar Alam et al, 2019, Molecular Imaging and Biology CrossRef